Sanofi's Combo Vaccines Gain FDA Fast Track Designation

Yahoo FinanceDec 12 04:34 ET

Antisense & RNAi Therapeutics Market Report 2024, Featuring Profiles of Alnylam Pharmaceuticals, Arbutus Biopharma, Benitec Biopharma, GSK, Ionis Pharmaceuticals, Sanofi, Sarepta Therapeutics & More - ResearchAndMarkets.com

BusinesswireDec 11 12:41 ET

Express News | Sanofi's Dual Influenza-COVID-19 Vaccines Receive FDA Fast Track Designation For Individuals 50 Years Of Age And Older

BenzingaDec 11 01:29 ET

Press Release: Two Combination Vaccine Candidates for Prevention of Influenza and COVID-19 Granted Fast Track Designation in the US

SanofiDec 11 00:00 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF) and NovoCure (NVCR)

TipRanksDec 10 07:11 ET · Ratings

AQEMIA Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting With London, UK

BusinesswireDec 10 03:29 ET